Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors

NCT06126406 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Colon Cancer
Rectal Cancer
Breast Cancer
Lung Cancer
Esophagus Cancer
Cholangiocarcinoma
Pancreas Cancer

Interventions

BIOLOGICAL: CEA-targeted CAR-T cells
BIOLOGICAL: CEA-targeted CAR-T cells

Sponsor

Chongqing Precision Biotech Co., Ltd

Collaborators

[object Object]